Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending August 23, 2015
Lung Function Patterns in Sickle Cell Anemia, Assessing patterns for early mortality
Emergency Room Visits in Sickle Cell Anemia, Associating lab test results with number of visits
Ferritin and DB in Sickle Cell Anemia, Are they associated with mortality?
Radiotherapy in DLBCL, Is it still relevant?
A Risk Index in Colorectal Cancer, Predicting the need for colonoscopy
Must reads for theWeek ending August 16, 2015
A Revised International Staging System for MM, New guideline improves prognostication
3q26.2 Rearrangements in CML, How do they affect prognosis?
Risk Level in Multiple Myeloma, Comparing prognoses for high risk vs standard risk
Cardiovascular Mortality in Hodgkin Lymphoma, Whose risk is highest?
ADT Plus Docetaxel in Metastatic Prostate Cancer, Assessing its effect on survival
Must reads for theWeek ending August 9, 2015
Multiple-Dose Rituximab in FCR Regimen, Is it efficacious in newly diagnosed CLL?
Cord Blood Transplantation in Leukemias, Comparing DCBT with URDT
Predicting Survival in Multiple Myeloma, A novel ratio may be key
Chronic Kidney Disease in CML, Are TKIs safe for CML patients?
Incidence of Histologic Subtypes in cHL, Assessing incidence in NS, MC, and NOS
Must reads for theWeek ending August 2, 2015
Weight Change in DLBCL, Studying change before and after therapy
Survival and Mortality in Promyelocytic Leukemia, Are rates the same in sAPL and de novo APL?
Bone Marrow Necrosis in AML and ALL, Evaluating its associations with response and survival
Distress In Patients With Bleeding Disorders, Surveying what causes it
Nonmyeloablative Allogenic HCT in MCL, Does it aid survival?
Must reads for theWeek ending July 26, 2015
Chimerism Testing in AML/MDS, Does it predict disease progression?
Stem Cell Transplant in MDS, Studying survival and GVHD incidence
Predictive Factors in Multiple Myeloma, Do baseline parameters predict response?
FDA approves Iressa for NSCLC, A new first-line therapy
FDA Approves PCR Test Kit, Identifies appropriate patients for Iressa